Determination of norfloxacin by fluorescence in the presence of different antacids: Quantification of analytical interferences

Journal of Pharmaceutical and Biomedical Analysis

Volumn 14, Issue 8-10, 1996, Pages 977-982

  Cordoba Borrego M ^a   Cordoba Diaz M ^a   Bernabe I ^a   Cordoba Diaz D ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Antacids; Chelate; Dissolution profile; Norfloxacin; Spectrofluorimetry

Indexed keywords

ALIGEST; ALMAGATE; ALUMINUM HYDROXIDE; ALUMINUM MAGNESIUM HYDROXIDE; ANTACID AGENT; CALCIUM CARBONATE; MAGALDRATE; MAGNESIUM HYDROXIDE; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SIMETHICONE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; CONFERENCE PAPER; DRUG DETERMINATION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STRUCTURE; FLUORESCENCE; PH; PHARMACEUTICS; PRIORITY JOURNAL; SPECTROFLUOROMETRY; STOMACH JUICE; TABLET; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 0030176324     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(96)01742-6     Document Type: Conference Paper

References (16)

1. Japan Pharmaceutical Reference. 1991;279-282 Japan Pharmaceutical, Medical & Dental Supply Exporters' Association, Tokyo.
2. Greenwood D., et al. J. Antimicrob. Chemother. 13:1984;315.
3. Ahumada A.A., et al. The pH/solubility profile of norfloxacin. S.T.P. Pharma. Sci. 3:1993;250-253.
4. Okazaki O., et al. Studies on the mechanism of pharmacokinetic interaction of aluminum hydroxide, an antacid, with new quinolones in rats. Xenobio. Metab. Dispos. 3:1988;387-394.
5. Campbell N.R.C., et al. Norfloxacin interaction with antacids and minerals. Br. J. Clin. Pharmacol. 33:1992;115-116.
6. Tanaka M., et al. Mechanistic study of inhibition of levofloxacin absorption by aluminum hydroxide. Antimicrob. Agents Chemother. 37:1993;2173-2178.
7. Lomaestro B., Bailie G. Quinolone - cation interactions: a review. DICP Ann. Pharmacother. 25:1991;1249-1258.
8. United States Pharmacopoeia (USP 23), 23rd revision, Mark Printing Company, Easton, 1995, p. 1104.
9. del Castillo B., et al. The use of fluorescent probes in pharmaceutical analysis. J. Pharm. Biomed. Anal. 6:1988;573-583.
10. Borner K., et al. Determination of sparfloxacin in serum and urine by high-performance-liquid-chromatography. J. Chromatogr. 579:1992;285-289.
11. Pascual A., et al. Fluorometric and high-performance-liquid-chromatographic measurement of quinolone uptake by human neutrophils. Eur. J. Clin. Microb. Infect. Dis. 10:1991;969-971.
12. Shibl A.M., et al. Determination of lomefloxacin in biological fluids by high-performance-liquid-chromatography and microbiological method. J. Clin. Pharm. Ther. 16:1991;353-359.
13. Schaefer H.G. Determination of BAY y 3118, a novel 4-quinolone, in biological fluids using high-performance-liquid-chromatography and photothermal post-column derivatization. J. Chromatogr. 616:1993;87-93.
14. Caporal J., et al. Validation analytique. Commentaries sur la note explicative européene et exemple d'application Rapport d'une commision STSTP. 6:1990;588-594. S.T.P., Pharm.
15. Senin P., et al. Convalida della taratura del metodo analitico. Boll. Chim. Farm. 3:1989;95-100.
16. Dalmau Roch R., et al. Control de calidad en la industria farmacéutica: concepto de validación. Ind. Farm. Invest. y Technol. 3:1989;85-91.